Abstract Four new sesquiterpenoids, namely 12-hydroxy-3-oxodrimenol (1), 11-hydroxyacetoxydrim-7-en-3b-ol (2), 2,6-dimethyl-7,10-epoxy-10-hydroxymethyldodeca-2,11-dien-6-ol (3), and 7,10-epoxy-2,6,10-trimethyldodeca-2,11-diene-4,6-diol (4), along with fourteen known compounds, were isolated from the cultures of Phellinidium sulphurascens. The structures of compounds 1-4 were established on the basis of extensive spectroscopic analysis. All of them were evaluated for their cytotoxic activities.
Introduction
The wood-decaying fungus Phellinidium sulphurascen is a rare species belonging to the genus Phellinidium which is close-related to the genus Phellinus taxonomically. So far, only seven species of this genus were discovered in China, including P. sulphurascens [1] . In addition, the genus Phellinus has plenty of bioactive secondary metabolites involved in different types, such as sesquiterpenoids, steroids, pigments and polysaccharides [2] [3] [4] [5] . Most of these metabolites showed significant vascular-relaxing [2] , antiviral [3] , estrogenic and anti-estrogenic [4] , and antitumor activities [5] . However, the fungus P. sulphurascens has not been chemically investigated until now. As our continuous search for bioactive natural products from higher fungi, it is of importance to carry out the chemical investigation on cultures of P. sulphurascens, which resulted in the isolation of four new sesquiterpennoids ( Fig. 1) , namely 12-hydroxy-3-oxodrimenol (1), 11-hydroxyacetoxydrim-7-en-3b-ol (2), 2,6-dimethyl-7,10-epoxy-10-hydroxymethyldodeca-2,11-dien-6-ol (3), and 7,10-epoxy-2,6,10-trimethyldodeca-2,11-diene-4,6-diol (4), together with fourteen known compounds, from the EtOAc extract of the cultures of this fungus. All compounds were evaluated for their cytotoxicities against five human cancer cell lines.
Results and Discussion
Compound 1, obtained as amorphous powder, possessed a molecular formula C 15 [6] , which suggested compound 1 possessed a drimane sesquiterpenoid skeleton. The notable difference between 1a and 1 was that the hydroxy group at C-3 (d C 79.7) in 1a was oxidized into a carbonyl group (d C 215.1) in 1, which caused the downfield shifts of C-4 from d C 39.8 in 1a to 47.9 in 1, and C-2 from d 28.1 in 1a to 38.7 in 1. The above assignment was further supported by the HMBC correlations from d H 1.08 (Me-14, s) and 1.02 (Me-15, s) to d C 215.1 (s, C-3) (Fig. 2) , as well as IR absorption band at 1701 cm -1 and mass data analysis. In the ROESY spectrum (Fig. 2) , cross peaks between Me-15/H-5, H-5/H-9, Me-13/H-11 were observed, which suggested that both Me-13 and H-11 should be b oriented. Therefore, compound 1 was established as 12-hydroxy-3-oxodrimenol (1).
Compound 2 was isolated as white powder. The molecular formula was established to be C 17 Table 1 ). These NMR spectroscopic data of 2 resembled those of a coexisting known compound acetoxydrim-7-en3b-ol (2a) [7] , except for the chemical shift of C-17 was 60.9 (CH 2 ) in 2 instead of 21.3 ppm (CH 3 ) in 2a. Therefore, compound 2 was established as a hydroxy derivative of 2a, which was also supported by the HMBC correlations from d H 4.13 (1H, d, J = 5.1 Hz) and 4.14 (1H, d, J = 5.1 Hz) to d C 173.5 (C-16, s) ( Fig. 2) , as well as mass data analysis. In the ROESY spectrum (Fig. 2 ), the cross peak of H-5/Me-15 suggested that C-14 was b oriented, while the cross peak of Me-15/H-3, as well as the constant coupling of H-3 (d H 3.26, dd, J = 11.3, 3.2 Hz), indicated 3-OH to be b oriented. Besides, the cross peaks of Me-14/ H-2, H-2/Me-13, Me-13/H-11 proved that H-9 was a oriented and Me-13 was b oriented. Therefore, compound 2 was elucidated as 11-hydroxyacetoxydrim-7-en-3b-ol.
Compound 3, a colorless oil, had an [M] ? peak at m/z 254.1873 in the HREIMS (cacld for 254.1882), corresponding to a molecular formula C 15 H 26 O 3 . 1D NMR spectra in combination with HSQC spectrum demonstrated 15 carbons, which were classified into three methyl, six methylenes (one olefinic carbon, one oxygenated carbon), three methines (two olefinic carbons) and three quaternary carbons (one olefinic carbon) ( Table 2 ). All these data suggested that compound 3 was a sesquiterpenoid possessing the same skeleton with 2,6,10-trimethyl-7,10- (Fig. 2) . In the RO-ESY spectrum (Fig. 2) , correlations of H-15/H-9b (d H 1.97) and H-9b/H-7 indicated that H-15 and H-7 were in the same side. Therefore, compound 3 was identified as 2,6-dimethyl-7,10-epoxy-10-hydroxymethyldodeca-2,11-dien-6-ol.
Compound 4 was isolated as a colorless oil. Its molecular formula was determined as C 15 ? ). Its NMR data were similar to those of 2,6,10-trimethyl-7,10-epoxy-2,11-dodecadien-6-ol [8] . Compared with compound 3, one proton at C-4 of compound 4 was substituted by a hydroxy, while Me-15 of 4 was not oxygenated. This change was supported by 1 H-1 H COSY correlation of H-4/H-5 and HMBC correlation of H-4/C-2 (Fig. 2) . The ROESY data suggested the other parts of 4 were same to those of 3 (Fig. 2) . Therefore, the structure of compound 4 was elucidated as 7,10-epoxy-2,6,10-trimethyldodeca-2,11-diene-4,6-diol.
Fourteen known compounds were identified as 3,11-dihydrodrimane [9] , 3b,11,12-trihydroxy-drimene (1a), 3b-hydroxydrimenol, 11,12-dihydroxydrimene [6] , acetoxydrim-7-en-3b-ol (2a) [7] , 3-keto-drimenol [10] , drimane-2,11-diol [11] , 11-hydroxydrim-8-en-7-one [12] , (-)-drimenol [13] , 15-hydroxy-T-muurolol [14] , 2b-hydroxyd-cadinol [15] , 2b-hydroxy-a-cadinol [16] , 3b-hydroxy-d- cadinol [17] , and 2-(5 0 -ethenyltetrahydro-5 0 -methylfuran-2 0 -yl)-6-methylhept-5-en-ol [18] by comparison of spectroscopic data with those reported in the literature.
Unfortunately, none of them showed significant inhibitory activities against the five human cancer cell lines ([ 40 lmol).
Experimental

General Experimental and Procedures
Optical rotations were obtained on a JASCO P-1020 digital polarimeter. IR and UV spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer with KBr pellets and a Shimadzu UV-2401PC instrument, respectively. 1D and 2D NMR spectra were obtained on a Bruker Avance III 600 MHz spectrometer. ESIMS and HREIMS were measured on a Waters Xevo TQ-S spectrometer and a Waters Autospec Premier P776 spectrometer, respectively. HRE-SIMS was measured on an Agilent G6230 TOF MS spectrometer. Silica gel 200-300 mesh (Qingdao Marine Chemical Inc., China) and Sephadex LH-20 (Amersham Biosciences, Sweden) were used for column chromatography. Medium pressure liquid chromatography (MPLC) was performed on a Büchi Sepacore System equipping pump manager C-615, pump modules C-605 and fraction collector C-660 (Büchi Labortechnik AG, Switzerland), and columns packed with Chromatorex C-18 (40-75 lm, Fuji Silysia Chemical Ltd., Japan). Preparative high performance liquid chromatography (Prep-HPLC) was performed on an Agilent 1260 liquid chromatography system equipped with a Zorbax SB-C18 column (5 lm, 9.4 9 150 mm). peptone from porcine meat (0.15 %), yeast powder (0.5 %), KH 2 PO 4 (0.05 %) and MgSO 4 (0.05 %). Five hundred 500-mL Erlenmeyer flasks each containing 350 mL of above-mentioned culture medium were inoculated with P. sulphurascens strains, respectively. Then they were incubated on rotary shakers at 24°C and 150 rpm for 25 days in dark environment.
Extraction and Isolation
The culture broth (20 L) of P. sulphurascens was filtered, the filtrate was extracted four times with ethyl acetate (EtOAc). Meanwhile, the mycelium was extracted by CHCl 3 /MeOH 
Cytotoxicity
The cytotoxicity assay was performed according to the MTT method in 96-well microplates. Five human cancer cell lines: human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast cancer MCF-7 and human colon cancer SW480 cells were used in the cytotoxicity assay. All the cells were cultured in RPMI-1640 or DMEM (Hyclone, Logan, UT, USA), supplemented with 10 % fetal bovine serum (Hyclone) in 5 % CO 2 at 37°C. Briefly, 100 lL of adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition with an initial density of 1 9 10 5 cells/mL. Each tumor cell line was exposed to the test compound at concentrations of 0.064, 0.32, 1.6, 8, and 40 lmol in triplicates for 48 h, with cisplatin (sigma, USA) as a positive control (IC 50 : SW480, 12.0 lmol; SMMC-7721, 10.2 lmol; HL-60, 3.1 lmol; MCF-7, 17.5 lmol; A-549, 9.1 lmol). After compound treatment, cell viability was detected and cell growth curve was graphed.
